Cyclacel Pharmaceuticals CYCC

Annual report 2025
added 03-30-2026

Cyclacel Pharmaceuticals DIO Ratio 2011-2026 | CYCC

Annual DIO Ratio Cyclacel Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-	-	-	185

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
185	185	185

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.89	-0.61 %	$ 6.54 M	China
	ACADIA Pharmaceuticals ACAD	295	$ 22.57	1.21 %	$ 3.74 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	CASI Pharmaceuticals CASI	47.4	-	-	$ 35.4 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	ChromaDex Corporation CDXC	69.7	-	-0.88 %	$ 598 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Aquestive Therapeutics AQST	120	$ 4.09	-0.37 %	$ 437 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 23.2	-0.96 %	$ 2.95 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.48	3.87 %	$ 394 M	Britain
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	CTI BioPharma Corp. CTIC	38.1	-	-	$ 1.2 B	USA
	BioXcel Therapeutics BTAI	1.56 K	$ 1.07	-1.83 %	$ 13.1 M	USA